Cisen Pharmaceutical Ltd. (603367) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Cisen Pharmaceutical Ltd.

Why is Cisen Pharmaceutical Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -1.10% and Operating profit at 0.34% over the last 5 years

The company has declared Negative results for the last 3 consecutive quarters

NET SALES(9M) At CNY 2,583.78 MM has Grown at -12.88%
INVENTORY TURNOVER RATIO(HY) Lowest at 2.15 times
OPERATING PROFIT(Q) Lowest at CNY 85.93 MM

With ROE of 7.41%, it has a very attractive valuation with a 1.48 Price to Book Value

Over the past year, while the stock has generated a return of 23.82%, its profits have fallen by -18.8%
At the current price, the company has a high dividend yield of 2.2

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Cisen Pharmaceutical Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Cisen Pharmaceutical Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Cisen Pharmaceutical Ltd.

16.2%

0.14

50.30%

China Shanghai Composite

13.33%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-1.10%

EBIT Growth (5y)

0.34%

EBIT to Interest (avg)

61.55

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.39

Sales to Capital Employed (avg)

0.67

Tax Ratio

9.90%

Dividend Payout Ratio

39.15%

Pledged Shares

Institutional Holding

ROCE (avg)

11.05%

ROE (avg)

7.85%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.48

EV to EBIT

16.25

EV to EBITDA

11.63

EV to Capital Employed

1.87

EV to Sales

1.73

PEG Ratio

Dividend Yield

2.21%

ROCE (Latest)

11.49%

ROE (Latest)

7.41%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 951.95 MM

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

RAW MATERIAL COST(Y)

Fallen by -2.07% (YoY

CASH AND EQV(HY)

Highest at CNY 6,479.45 MM

DEBT-EQUITY RATIO (HY)

Lowest at -49.77 %

PRE-TAX PROFIT(Q)

Highest at CNY 163.81 MM

NET PROFIT(Q)

Highest at CNY 150.09 MM

EPS(Q)

Highest at CNY 0.34

-5What is not working for the Company

NET SALES(9M)

At CNY 2,583.78 MM has Grown at -12.88%

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.15 times

OPERATING PROFIT(Q)

Lowest at CNY 85.93 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 10.18 %

Here's what is working for Cisen Pharmaceutical Ltd.

Operating Cash Flow

Highest at CNY 951.95 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Pre-Tax Profit

Highest at CNY 163.81 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 150.09 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.34

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Cash and Eqv

Highest at CNY 6,479.45 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio

Lowest at -49.77 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by -2.07% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Cisen Pharmaceutical Ltd.

Net Sales

At CNY 2,583.78 MM has Grown at -12.88%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 85.93 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 10.18 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Inventory Turnover Ratio

Lowest at 2.15 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Non Operating Income

Highest at CNY 0.47 MM

in the last five periods

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating income